According to Tempest Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.11. In 2022 the company made an earnings per share (EPS) of -$5.63 an increase over its 2021 EPS that were of -$18.59.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.91 | -30.51% |
2022 | -$5.63 | -69.74% |
2021 | -$18.59 |